Kringle Pharma, Inc. (TYO:4884)
510.00
-64.00 (-11.15%)
Nov 18, 2026, 10:50 AM JST
Kringle Pharma Market Cap
Kringle Pharma has a market cap or net worth of 4.28 billion as of November 17, 2026. It is the 33,983rd most valuable company in the world and the 3,111th biggest in Japan. Its market cap has increased by 42.34% in one year.
Market Cap
4.28B
Enterprise Value
2.59B
Revenue
442.00M
Global Rank
Country Rank
#3,111 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 28, 2020, Kringle Pharma's market cap has decreased from 5.09B to 4.28B, a decrease of -15.94%. That is a compound annual growth rate of -2.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 4.43B | 56.98% |
| Dec 30, 2025 | 2.82B | -52.49% |
| Dec 30, 2024 | 5.95B | 30.66% |
| Dec 29, 2023 | 4.55B | 47.85% |
| Dec 30, 2022 | 3.08B | -0.04% |
| Dec 30, 2021 | 3.08B | -45.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nano Holdings | 6.10B |
| Chiome Bioscience | 6.08B |
| CellSource | 5.60B |
| Soiken Holdings | 5.52B |
| BrightPath Biotherapeutics | 5.28B |
| Cyfuse Biomedical K.K. | 5.12B |
| MabGenesis | 4.91B |
| MEDINET | 4.84B |